No Level 4 CDC travel health notice has been issued as of mid-June 2026, with official monitoring showing zero countries at "Avoid All Travel" status despite ongoing surveillance for dengue, measles surges, and isolated Ebola-related screening. Traders see limited near-term risk of escalation to Level 4 criteria—an extreme health risk with no effective precautions—because current case trajectories and transmission patterns remain below thresholds that historically triggered such alerts, as seen in lower-level advisories for mosquito-borne illness. Seasonal factors, vaccination coverage, and absence of novel high-impact variants or widespread outbreaks further support the 75% "No" consensus through year-end, though evolving model projections or unexpected case clusters could shift dynamics before December.